[Lymphoma in patients harboring hepatosplenic mansonic schistosomiasis]

Alvaro Antônio Bandeira Ferraz1, Vladimir Curvêlo Tavares de Sá, Edmundo Pessoa de Almeida Lopes

  • 1Departamento de Cirurgia, Universidade Federal de Pernambuco, Recife, PE. aabf@truenet.com.br

Abstract

Insights

This study highlights a 2.36% incidence of lymphomas in patients with hepatosplenic schistosomiasis mansoni. These findings underscore the critical link between schistosomiasis mansoni infection and lymphoid malignancies.

Area of Science:

  • Medical Research
  • Oncology
  • Infectious Diseases

Background:

  • Infectious agents, particularly viruses and bacteria, are increasingly linked to lymphoproliferative diseases via lymphocyte activation.
  • Schistosomiasis mansoni is a parasitic infection with a known hepatosplenic form.

Observation:

  • Six new cases of lymphoma were identified in 254 patients (2.36%) with hepatosplenic schistosomiasis mansoni.
  • All identified cases occurred in female patients.
  • Histopathological examination revealed various types of lymphomas, including marginal zone lymphomas, diffuse lymphomas, and Hodgkin lymphoma.

Findings:

  • Half of the patients diagnosed with lymphoma and schistosomiasis mansoni died within 4-15 months post-diagnosis.
  • The remaining three patients continue to receive care in the Oncology Division.
  • The study establishes a 2.36% incidence of lymphomas among the observed schistosomiasis mansoni cohort.

Implications:

  • This research emphasizes the importance of considering lymphoma in patients diagnosed with hepatosplenic schistosomiasis mansoni.
  • Increased awareness and diagnostic vigilance for lymphomas in this patient population are warranted.
  • Further research into the mechanisms underlying the association between schistosomiasis mansoni and lymphoma development is crucial.